UCLA
Jonathan W. Goldman, M.D. is an Associate Professor of Medicine at UCLA in the Hematology/Oncology Division. He is the Director of Clinical Trials in Thoracic Oncology and the Associate Director of Early Drug Development. Dr. Goldman’s research is focused on improving the treatment for thoracic malignancies and other cancers.
AstraZeneca (Individual(s) Involved: Self): Advisory Board, Consultant, Grant/Research Support; Genentech (Individual(s) Involved: Self): Advisory Board, Consultant, Grant/Research Support; GSK (Individual(s) Involved: Self): Grant/Research Support; Jazz Pharmaceuticals (Individual(s) Involved: Self): Advisory Board; Merck (Individual(s) Involved: Self): Grant/Research Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support
Wednesday, November 9, 2022
9:00 AM – 10:45 AM
Wednesday, November 9, 2022
9:15 AM – 9:35 AM
Wednesday, November 9, 2022
10:20 AM – 10:45 AM
Wednesday, November 9, 2022
1:40 PM – 1:55 PM
Wednesday, November 9, 2022
1:35 PM – 2:50 PM
Wednesday, November 9, 2022
2:25 PM – 2:50 PM